Antibody Response After Initial Vaccination for SARS-CoV-2 in Patients With Amyloidosis

• Efstathios Kastritis,
• Evangelos Terpos,
• Aimilia Sklirou,
• Foteini Theodorakakou,
• Despina Fotiou,
• Eleni-Dimitra Papanagnou,
• Tina Bagratuni,
• Nikolaos Kanellias,
• Maria Gavriatopoulou,
• Ioannis P. Trougakos,
• Meletios A. Dimopoulos

Affiliations

Efstathios Kastritis

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Evangelos Terpos

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Aimilia Sklirou

2 Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Greece

Foteini Theodorakakou

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Despina Fotiou

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Eleni-Dimitra Papanagnou

2 Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Greece

Tina Bagratuni

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Nikolaos Kanellias

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Maria Gavriatopoulou

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Ioannis P. Trougakos

2 Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Greece

Meletios A. Dimopoulos

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece